You have 9 free searches left this month | for more free features.

Progressive MS

Showing 1 - 25 of 7,455

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Multiple Sclerosis, Chronic Progressive Trial in United States (NurOwn (MSC-NTF cells))

Completed
  • Multiple Sclerosis, Chronic Progressive
  • NurOwn (MSC-NTF cells)
  • Los Angeles, California
  • +3 more
Oct 20, 2022

Primary Progressive Multiple Sclerosis, Secondary Progressive Multiple Sclerosis, Multiple Sclerosis Trial (Intranasal Foralumab

Withdrawn
  • Primary Progressive Multiple Sclerosis
  • +2 more
  • Intranasal Foralumab Solution
  • Placebo
  • (no location specified)
Feb 14, 2022

Gray Matter Demyelination in Primary Progressive MS at 7T

Recruiting
  • Primary Progressive Multiple Sclerosis
    • Hvidovre, Denmark
      Danish Research Centre for Magnetic Resonance
    Jun 5, 2022

    Multiple Sclerosis (MS) Patients

    Not yet recruiting
    • Multiple Sclerosis, Relapsing-Remitting
    • +2 more
      • (no location specified)
      Dec 15, 2022

      Multiple Sclerosis, Primary Progressive Multiple Sclerosis, Secondary-progressive Multiple Sclerosis Trial in Belgium (Metformin

      Not yet recruiting
      • Multiple Sclerosis
      • +2 more
      • Metformin Hydrochloride 850 mg Oral Tablet
      • Placebo
      • Brugge, Belgium
      • +4 more
      May 30, 2023

      Multiple Sclerosis, Secondary Progressive, Multiple Sclerosis Trial in Warsaw (Cladribine Subcutaneous Injection, 0.9% Chloride

      Recruiting
      • Multiple Sclerosis, Secondary Progressive
      • Multiple Sclerosis
      • Cladribine Subcutaneous Injection
      • 0.9% Chloride Injection Sodium
      • Warsaw, Mazowieckie, Poland
        Institute of Psychiatry and Neurology
      Jul 26, 2023

      Primary Progressive Multiple Sclerosis, Secondary Progressive Multiple Sclerosis, Relapsing Multiple Sclerosis Trial in Boston

      Recruiting
      • Primary Progressive Multiple Sclerosis
      • +3 more
      • Boston, Massachusetts
        Brigham and Women's Hospital
      Jul 20, 2021

      Multiple Sclerosis, Relapsing-Remitting, Multiple Sclerosis, Secondary Progressive, Multiple Sclerosis, Primary Progressive

      Completed
      • Multiple Sclerosis, Relapsing-Remitting
      • +2 more
      • 18F-DPA-714 and 18F-FDG
      • Paris, France
      • +1 more
      Sep 14, 2022

      Multiple Sclerosis (MS), Multiple Sclerosis, Relapsing-Remitting, Multiple Sclerosis, Primary Progressive Trial in San Francisco

      Not yet recruiting
      • Multiple Sclerosis (MS)
      • +6 more
      • Clemastine Fumarate
      • Placebo
      • San Francisco, California
        Sandler Neurosciences Building, Neurological Clinical Research U
      Jan 23, 2023

      Multiple Sclerosis (MS) Registries

      Active, not recruiting
      • Progressive Multifocal Leukoencephalopathy
      • Tysabri
      • Cambridge, Massachusetts
        Research Site
      Mar 21, 2022

      Progressive Multiple Sclerosis, Fatigue Trial in San Francisco (N-acetyl cysteine, Placebo)

      Completed
      • Progressive Multiple Sclerosis
      • Fatigue
      • N-acetyl cysteine
      • Placebo
      • San Francisco, California
        University of California San Francisco
      Sep 6, 2022

      Multiple Sclerosis Trial in Cardiff (LEAP-MS)

      Completed
      • Multiple Sclerosis
      • LEAP-MS
      • Cardiff, United Kingdom
        Centre for Trials Research
      Jul 1, 2021

      Multiple Sclerosis, Chronic Progressive, Multiple Sclerosis, Primary Progressive Trial in Kaposvár (Training groupe, PNF,

      Completed
      • Multiple Sclerosis, Chronic Progressive
      • Multiple Sclerosis, Primary Progressive
      • Training groupe
      • +3 more
      • Kaposvár, Somogy, Hungary
        Somogy Megyei Kaposi Mór Oktató Kórház
      Mar 24, 2022

      Multiple Sclerosis Trial in France (Ocrelizumab)

      Recruiting
      • Multiple Sclerosis
      • Amiens, France
      • +14 more
      Jul 12, 2022

      Secondary Progressive Multiple Sclerosis, Primary Progressive Multiple Sclerosis, Progressive Relapsing Multiple Sclerosis Trial

      Active, not recruiting
      • Secondary Progressive Multiple Sclerosis
      • +2 more
      • Minneapolis, Minnesota
      • +2 more
      Mar 29, 2022

      Multiple Sclerosis Trial in Canada, United States (Lipoic acid, Placebo)

      Active, not recruiting
      • Multiple Sclerosis
      • Lipoic acid
      • Placebo
      • Birmingham, Alabama
      • +10 more
      Jan 31, 2023

      Multiple Sclerosis Trial in New York (Active RS-tDCS +At-Home Manual Dexterity Training, Sham RS-tDCS +At-Home Manual Dexterity

      Completed
      • Multiple Sclerosis
      • Active RS-tDCS +At-Home Manual Dexterity Training
      • +2 more
      • New York, New York
        New York University School of Medicine
      Feb 11, 2022

      Multiple Sclerosis Trial in New York (Intrathecal MSC-NP injection, Intrathecal saline injection)

      Active, not recruiting
      • Multiple Sclerosis
      • Intrathecal MSC-NP injection
      • Intrathecal saline injection
      • New York, New York
        Tisch MS Research Center of New York
      Oct 25, 2022

      Primary Progressive Multiple Sclerosis, Secondary Progressive Multiple Sclerosis Trial in Australia, Canada, United States

      Active, not recruiting
      • Primary Progressive Multiple Sclerosis
      • Secondary Progressive Multiple Sclerosis
      • ATA188
      • Placebo
      • La Jolla, California
      • +33 more
      Jul 21, 2022

      Multiple Sclerosis Trial in New York (Intrathecal MSC-NP injection)

      Temporarily not available
      • Multiple Sclerosis
      • Intrathecal MSC-NP injection
      • New York, New York
        Tisch MS Research Center of New York
      Feb 7, 2022

      MS-ResearchBiomarkerS

      Recruiting
      • Multiple Sclerosis
      • +10 more
        • Los Angeles, California
          Cedars-Sinai Medical Center
        Jan 26, 2022

        Automated EDSS Score Calculation by Smartphone Application

        Completed
        • MS CHRONIC PROGRESSIVE
        • neurological exam
        • Nice, France
          Nice University Hospital
        Mar 17, 2022

        Imaging Interplay Between Axonal Damage and Repair in Multiple

        Recruiting
        • Multiple Sclerosis (MS)
        • +3 more
        • MRI
        • +2 more
        • Basel, Switzerland
          University Hospital Basel, Department of Neurology
        Dec 15, 2021

        Multiple Sclerosis, Primary Progressive Trial in Calgary (Hydroxychloroquine)

        Completed
        • Multiple Sclerosis, Primary Progressive
        • Calgary, Alberta, Canada
          MS Clinic Foothills Medical Centre
        Jul 28, 2021

        MS - a Prospective Cohort Study

        Active, not recruiting
        • Multiple Sclerosis, Relapsing-Remitting
        • +2 more
        • PASS-MS
        • Berlin, Germany
          Experimental and Clinical Research Center, Studienambulanz Neuro
        Aug 9, 2021